406 related articles for article (PubMed ID: 8296501)
1. [The contrast enhancement of brain and spinal cord tumors using Gd-DTPA in magnetic resonance tomography with an extra-low magnetic-field intensity].
Kornienko VN; Pronin IN; Turkin AM; Fadeeva LM
Zh Vopr Neirokhir Im N N Burdenko; 1993; (4):13-7. PubMed ID: 8296501
[TBL] [Abstract][Full Text] [Related]
2. [Gd-DTPA in the diagnosis of brain metastasis].
Kornienko VN; Pronin IN
Vestn Rentgenol Radiol; 1994; (5):5-10. PubMed ID: 7785209
[TBL] [Abstract][Full Text] [Related]
3. [Nuclear magnetic resonance tomography using gadolinium-DTPA in the diagnosis of spinal lesions].
Fenzl G; Heywang SH; Vogl T
Rofo; 1988 Apr; 148(4):415-8. PubMed ID: 2834789
[TBL] [Abstract][Full Text] [Related]
4. [Acoustic neurinomas. Magnetic resonance tomography using the contrast medium Gd-DTPA].
Pronin IN; Kornienko VN
Zh Vopr Neirokhir Im N N Burdenko; 1995; (2):16-7. PubMed ID: 7625134
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging in small lesions of the central nervous system. Improvement by gadolinium-DTPA.
Schroth G; Grodd W; Guhl L; Grauer M; Klose U; Niendorf HP
Acta Radiol; 1987; 28(6):667-72. PubMed ID: 2962598
[TBL] [Abstract][Full Text] [Related]
6. [Brain and spinal tumors: magnetic resonance imaging using gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)].
Fang YX
Zhonghua Yi Xue Za Zhi; 1989 Jun; 69(6):305-7, 22. PubMed ID: 2804747
[TBL] [Abstract][Full Text] [Related]
7. [Experience in clinical use of paramagnetic agent magnevist in the diagnosis of spine and spinal cord metastases].
Gunicheva NV; Akhadov TA; Grakova LS; Batukhtin EN
Vestn Rentgenol Radiol; 1996; (6):15-8. PubMed ID: 9027071
[TBL] [Abstract][Full Text] [Related]
8. [Magnetic resonance tomography using the contrast preparation Magnevist].
Tiutin LA; Panfilenko AF; Arzumanova NV; Fedotova IG; Berezin SM; Shelkoplias EN
Vestn Rentgenol Radiol; 1996; (2):6-13. PubMed ID: 8754114
[TBL] [Abstract][Full Text] [Related]
9. Application of Gd-DTPA in diseases of the central nervous system.
Shen TZ; Mei H; Huang XL; Chen XR
Chin Med J (Engl); 1991 Apr; 104(4):313-20. PubMed ID: 2065550
[TBL] [Abstract][Full Text] [Related]
10. Gd-DTPA-enhanced MR imaging of spinal tumors.
Parizel PM; Balériaux D; Rodesch G; Segebarth C; Lalmand B; Christophe C; Lemort M; Haesendonck P; Niendorf HP; Flament-Durand J
AJR Am J Roentgenol; 1989 May; 152(5):1087-96. PubMed ID: 2705343
[TBL] [Abstract][Full Text] [Related]
11. [Changes in tissue T1 of brain tumor following GD-DTPA administration--differences in T1 time course and tissue-blood ratio by histological types].
Yoshida K; Furuse M; Kaneoke Y; Sasou K; Motegi Y
No To Shinkei; 1988 Jun; 40(6):531-7. PubMed ID: 3224029
[TBL] [Abstract][Full Text] [Related]
12. [Gadolinium-DTPA in magnetic resonance tomography. Clinical use--indications].
Prayer L; Imhof H; Stiglbauer R; Kramer J; Wimberger D
Rontgenblatter; 1989 Dec; 42(12):493-8. PubMed ID: 2609069
[TBL] [Abstract][Full Text] [Related]
13. [Optimization of gadolinium-DTPA dose: an inter-individual study of patients with intracranial tumors].
Schubeus P; Schörner W; Haustein J; Hosten N; Niendorf HP; Felix R
Rofo; 1990 Jul; 153(1):29-35. PubMed ID: 2166308
[TBL] [Abstract][Full Text] [Related]
14. [Gadolinium DTPA in magnetic resonance. Clinical experience in intracranial pathology].
Bradac GB; Riva A; Berger T; Stura G; Duca S
Radiol Med; 1988; 76(1-2):33-7. PubMed ID: 3399707
[TBL] [Abstract][Full Text] [Related]
15. [MRI of spinal cord tumor--contrast enhancement effect of Gd-DTPA].
Yuyama T; Itabashi T; Arimizu N; Okada J; Uematu S
Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Jan; 48(1):29-37. PubMed ID: 3401298
[No Abstract] [Full Text] [Related]
16. [Use of Omniscan (gadodiamide) in magnetic resonance studies of the central nervous system (results of a multicenter study)].
Sinitsyn VE; Kornienko VN; Nikitin VG; Pronin IN; Ternovoĭ SK; Tiutin LA; Iakobson MG
Vestn Rentgenol Radiol; 1995; (4):5-11. PubMed ID: 8571538
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of CH3-DTPA-Gd (NMS60) as a new MR contrast agent: early phase II study in brain tumors and dual dynamic contrast-enhanced imaging.
Ito M; Ogino H; Oshima H; Shiraki N; Shibamoto Y; Kasai H; Mase M; Kawamura Y; Miyati T
Magn Reson Imaging; 2006 Jun; 24(5):625-30. PubMed ID: 16735185
[TBL] [Abstract][Full Text] [Related]
18. [Gadolinium-DTPA in the study of intracranial tumors in the adult].
Grégoire N; Momose T; Rumeau C; Perot S; Girard N; Lavanga A; Salamon G
Rev Neurol (Paris); 1990; 146(2):133-43. PubMed ID: 2320818
[TBL] [Abstract][Full Text] [Related]
19. [Use of magnevist in the clinical practice (clinical trials].
Cheremisin VM; Miakotin LL; Kovelenov AG; Trushchenko SG
Vestn Rentgenol Radiol; 1994; (4):22-5. PubMed ID: 7785194
[No Abstract] [Full Text] [Related]
20. Gadolinium-DTPA in spinal disease.
Sze G
Radiol Clin North Am; 1988 Sep; 26(5):1009-24. PubMed ID: 3420235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
